Public Cannabis Company Revenue Tracker
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5m per quarter. This data-driven, fact-based tracker will continually update based on new filings so that readers can stay up to date. Companies must file with the SEC or SEDAR to be considered for inclusion.
U.S. Cannabis Market
| Company Name | Stock Symbol | Quarter Ended | Quarterly Sales | Y/Y Growth | Next Financials |
|---|---|---|---|---|---|
| Terra Tech | (OTCQX: TRTC) | 06/30/17 | $6.05m | 61% | ~11/09/17 |
| Kush Bottles | (OTCQB: KSHB) | 05/31/17 | $4.72m | 103% | ~11/29/17 |
| GrowGeneration | (OTCQB: GRWG) | 06/30/17 | $4.11m | 116% | ~11/14/17 |
| CV Sciences | (OTCQB: CVSI) | 06/30/17 | $4.08m | 64% | ~11/14/17 |
| GW Pharma | (NASDAQ: GWPH) | 06/30/17 | $3.14m | 3% | ~12/14/17 |
Canadian Cannabis Market
| Company Name | Stock Symbol | Quarter Ended | Quarterly Sales | Y/Y Growth | Next Financials |
|---|---|---|---|---|---|
| Canopy Growth | (TSX: WEED) | 06/30/17 | C$15.87m | 127% | ~11/14/17 |
| MedReleaf | (TSX: LEAF) | 06/30/17 | C$10.46m | 19% | ~11/14/17 |
| Aphria | (TSX: APH) | 05/31/17 | C$5.72m | 106% | ~10/16/17 |
| Aurora Cannabis | (TSX: ACB) | 03/31/17 | C$5.18m | 2263% | ~9/28/17 |
| CanniMed Therapeutics | (TSX: CMED) | 04/30/17 | C$3.69m | 66% | ~9/14/17 |
| Namaste Technologies | (CSE: N) | 05/31/17 | C$3.16m | 328% | ~12/29/17 |
Note: Sales are cannabis-only if the company breaks out revenue by segment. For more information or questions, please email us. The Public Cannabis Company Revenue Tracker by New Cannabis Ventures is not a recommendation of any company and you should not use it as investment advice. A tilde next to a date means approximate date. All computations are derived from SEC or SEDAR filings.
